Skip to content
Q3 '26Q2 '26Q1 '26Q4 '25Q3 '25
-$34.17M-4.2%-$32.79M-26.9%-$25.83M+49.5%-$51.11M-135%-$21.76M-5.5%
$1.98M-16.4%$2.37M+17.0%$2.03M+10.5%$1.84M-2.8%$1.89M+1.0%
$10.11M+16.8%$8.65M+89.0%$4.58M-79.5%$22.31M+4,761%$459K-59.1%
-$18.37M-0.1%-$18.34M+30.2%-$26.27M-9.2%-$24.06M-33.7%-$18M+0.3%
$9.8M+34.9%$7.27M-11.0%$8.17M+10.5%$7.39M+81.9%$4.06M-8.6%
-$14.92M-101%-$7.42M+9.9%-$8.23M-11.2%-$7.4M-66.4%-$4.45M-0.7%
$149.18M+552,626%-$27K+98.6%-$1.88M-101%$214.7M
$115.9M+549%-$25.79M+29.1%-$36.38M-120%$183.24M
-$28.16M-10.0%-$25.61M+25.6%-$34.44M-9.5%-$31.45M-42.5%-$22.06M+2.0%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

How much cash does Kestra Medical Technologies, Ltd. Common Stock generate?
Kestra Medical Technologies, Ltd. Common Stock (KMTS) generated -$87.0M in operating cash flow over the trailing twelve months.
What is Kestra Medical Technologies, Ltd. Common Stock's free cash flow?
After $32.6M of capital expenditures, Kestra Medical Technologies, Ltd. Common Stock's free cash flow was -$119.7M over the trailing twelve months, down 32.6% year over year.
Where does Kestra Medical Technologies, Ltd. Common Stock's cash flow data come from?
Every line is extracted from Kestra Medical Technologies, Ltd. Common Stock's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.